Search Results - "Plütschow, Annette"

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

Gillessen, Sarah, Plütschow, Annette, Fuchs, Michael, Markova, Jana, Greil, Richard, Topp, Max S, Meissner, Julia, Zijlstra, Josée M, Eichenauer, Dennis A, Bröckelmann, Paul J, Diehl, Volker, Borchmann, Peter, Engert, Andreas, von Tresckow, Bastian ^*

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

Borchmann, Peter, Plütschow, Annette, Kobe, Carsten, Greil, Richard, Meissner, Julia, Topp, Max S, Ostermann, Helmut, Dierlamm, Judith, Mohm, Johannes, Thiemer, Julia, Sökler, Martin, Kerkhoff, Andrea, Ahlborn, Miriam, Halbsguth, Teresa V, Martin, Sonja, Keller, Ulrich, Balabanov, Stefan, Pabst, Thomas, Vogelhuber, Martin, Hüttmann, Andreas, Wilhelm, Martin, Zijlstra, Josée M, Moccia, Alden, Kuhnert, Georg, Bröckelmann, Paul J, von Tresckow, Bastian, Fuchs, Michael, Klimm, Beate, Rosenwald, Andreas, Eich, Hans, Baues, Christian, Marnitz, Simone, Hallek, Michael, Diehl, Volker, Dietlein, Markus, Engert, Andreas ^*

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group

Damaschin, Carla^{Aff1, Aff2}, Goergen, Helen^{Aff1, Aff2}, Kreissl, Stefanie^{Aff1, Aff2}, Plütschow, Annette^{Aff1, Aff2}, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Sökler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian^{Aff2, Aff10}, Fuchs, Michael^{Aff1, Aff2}, Engert, Andreas^{Aff1, Aff2}, Borchmann, Peter^{Aff1, Aff2}, Eichenauer, Dennis A.^{Aff1, Aff2, IDs4137502101386z_cor16}

This result is not displayed to guests.
Login for full access.

Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group

Eichenauer, Dennis A., Plütschow, Annette, Schröder, Lena, Fuchs, Michael, Böll, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter, Engert, Andreas

Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group

Eichenauer, Dennis A.^{Aff1, Aff2}, Plütschow, Annette^{Aff1, Aff2}, Fuchs, Michael^{Aff1, Aff2}, Hartmann, Sylvia, Hansmann, Martin-Leo, Böll, Boris^{Aff1, Aff2}, von Tresckow, Bastian^{Aff1, Aff2}, Borchmann, Peter^{Aff1, Aff2}, Engert, Andreas^{Aff1, Aff2}

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group

Eichenauer, Dennis A, Plütschow, Annette, Kreissl, Stefanie, Sökler, Martin, Hellmuth, Johannes C, Meissner, Julia, Mathas, Stephan, Topp, Max S, Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas, Borchmann, Peter

Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma.

Müller‐Meinhard, Berit, Seifert, Nicole, Grund, Johanna, Reinke, Sarah, Yalcin, Fatih, Kaul, Helen, Borchmann, Sven, von Tresckow, Bastian, Borchmann, Peter, Plütschow, Annette, Richter, Julia, Engert, Andreas, Altenbuchinger, Michael, Bröckelmann, Paul J., Klapper, Wolfram

This result is not displayed to guests.
Login for full access.

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Hartmann, Sylvia, Eichenauer, Dennis A., Plütschow, Annette, Mottok, Anja, Bob, Roshanak, Koch, Karoline, Bernd, Heinz-Wolfram, Cogliatti, Sergio, Hummel, Michael, Feller, Alfred C., Ott, German, Möller, Peter, Rosenwald, Andreas, Stein, Harald, Hansmann, Martin-Leo, Engert, Andreas, Klapper, Wolfram

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)

Gillessen, Sarah, Hüttmann, Andreas, Vucinic, Vladan, Müller, Horst, Plütschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Böll, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Bröckelmann, Paul J., Heger, Jan‐Michel, Fuchs, Michael, Engert, Andreas, Borchmann, Peter, von Tresckow, Bastian

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.